Join us at the MPS World Summit 2022
We are delighted to be attending the inaugural Microphysiological Systems (MPS) World Summit in New Orleans – May 30th – June 3rd
This event brings together a global audience of key stakeholders to shape the future roadmap for MPS technologies, train the next generation of MPS scientists and share valuable insights.
Come and say hello – booth #122
Our team of experts will be available to meet you at booth #122 to answer all your questions.
You can also view a snapshot of our activities throughout the week below.
Customers: don’t forget to sign up for our update meeting and dinner here.
David Hughes, CEO
Brian Manning, US Head of Sales
Tomasz Kostrzewski, VP – Science & Technology
Anthony Berger, Field Application Scientist
Emily Richardson, Lead Scientist
Audrey Dubourg, Product Manager OOC
Alveolar and bronchial human microphysiological systems for use in respiratory infection research and therapeutics evaluation.
Emily Richardson, Hailey Sze, Lucy Young, Tomasz Kostrzewski, David Hughes – CN Bio
Why two organs are better than one: a gut-liver microphysiological system that mimics human oral and intravenous dosing regimens for improved prediction of oral bioavailability
Yassen Abbas, Tomasz Kostrzewski and David Hughes – CN Bio
How to effectively use human microphysiological systems to assess ADME properties of novel drug compounds
Tomasz Kostrzewski & Dr Emily Richardson, CN-Bio
Characterizing the reproducibility of a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation – joint study by an MPS developer and a regulator
Tomasz Kostrzewski, CN-Bio
Moderators: Emily Richardson, CN-Bio, UK and Abhinav Bhushan, Illinois Institute of Technology, USA
88. Complex in vitro models Representing the Pulmonary System
Arno Gutleb, Luxembourg Institute of Science and Technology, Luxembourg
2:15 pm – 2:35 pm
44. Development of the Human-Relevant Aerosol Test Platform HUMIMIC–InHALES for Evaluating Respiratory Toxicity and Systemic Effects of Inhaled Aerosols
Kasper Renggli, Philip Morris International, USA
2:35 pm – 2:55 pm
100. An Advanced Drug Screening Platform for Respiratory Viruses
Mirjam Kiener, AlveoliX, Switzerland
2:55 pm – 3:15 pm
Marc Ferrer, National Institutes of Health, National Center for Advancing Translational Sciences, USA.
3:15 pm – 3:35 pm